10x Genomics
General Information | |
Business: |
We are a life science technology company building products to interrogate, understand and master biology. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. We have built deep expertise across diverse disciplines including chemistry, biology, hardware and software. Innovations in all of these areas have enabled our rapidly expanding suite of products, which allow our customers to interrogate biological systems at previously inaccessible resolution and scale. |
Industry: | LABORATORY ANALYTICAL INSTRUMENTS |
Employees: | 500 |
Founded: | 2012 |
Contact Information | |
Address | 6230 Stoneridge Mall Road, Pleasanton, CA 94588, US |
Phone Number | (925) 401-7300 |
Web Address | https://www.10xgenomics.com |
View Prospectus: | 10x Genomics |
Financial Information | |
Market Cap | $3660.1mil |
Revenues | $196.6 mil (last 12 months) |
Net Income | $-105.4 mil (last 12 months) |
IPO Profile | |
Symbol | TXG |
Exchange | NASDAQ |
Shares (millions): | 10.0 |
Price range | $39.00 - $39.00 |
Est. $ Volume | $390.0 mil |
Manager / Joint Managers | J.P. Morgan/ Goldman Sachs/ BofA Securities |
CO-Managers | Cowen and Company |
Expected To Trade: | 9/12/2019 |
Status: | Priced |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |